Corrigendum to: 'An international Delphi consensus regarding best practice recommendations for hyperkalaemia across the cardiorenal spectrum' and articles listed below.

Abstract

European Journal of Heart FailureEarly View CORRECTIONFree Access Correction to: “An international Delphi consensus regarding best practice recommendations for hyperkalaemia across the cardiorenal spectrum” and articles listed below This article corrects the following: An international Delphi consensus regarding best practice recommendations for hyperkalaemia across the cardiorenal spectrum James O. Burton, Andrew J.S. Coats, Csaba P. Kovesdy, Biff F. Palmer, Ileana L. Piña, Giuseppe Rosano, Manish M. Sood, Shelley Zieroth, Volume 24Issue 9European Journal of Heart Failure pages: 1467-1477 First Published online: August 4, 2022 First published: 17 February 2023 https://doi.org/10.1002/ejhf.2790AboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Funding section was not complete. This should have read: Funding: This study was supported by the Italian Ministry of Health (Ricerca Corrente) 20/1819. The affected articles are listed in the reference list. We apologize for these errors. References 1Burton JO, Coats AJS, Kovesdy CP, Palmer BF, Piña IL, Rosano G, et al. An international Delphi consensus regarding best practice recommendations for hyperkalaemia across the cardiorenal spectrum. Eur J Heart Fail. 2022; 24: 1467– 77. 2D'Amario D, Rodolico D, Rosano GMC, Dahlström U, Crea F, Lund LH, et al. Association between dosing and combination use of medications and outcomes in heart failure with reduced ejection fraction: data from the Swedish heart failure registry. Eur J Heart Fail. 2022; 24: 871– 84. 3Bayés-Genís A, Aimo A, Metra M, Anker S, Seferovic P, Rapezzi C, et al. Head-to-head comparison between recommendations by the ESC and ACC/AHA/HFSA heart failure guidelines. Eur J Heart Fail. 2022; 24: 916– 26. 4Metra M, Jankowska EA, Pagnesi M, Anker SD, Butler J, Dorigotti F, et al.; the AFFIRM-AHF Investigators. Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM-AHF trial. Eur J Heart Fail. 2022; 24: 1928– 39. 5Rosano GMC, Celant S, Olimpieri PP, Colatrella A, Onder G, Di Lenarda A, et al. Impact of the COVID-19 pandemic on prescription of sacubitril/valsartan in Italy. Eur J Heart Fail. 2022; 24: 855– 60. 6Piepoli MF, Adamo M, Barison A, Bestetti RB, Biegus J, Böhm M, et al. Preventing heart failure: a position paper of the heart failure association in collaboration with the European Association of Preventive Cardiology. Eur J Heart Fail. 2022; 24: 143– 68. 7Anker SD, Ponikowski P, Khan MS, Friede T, Jankowska EA, Fabien V, et al. Responder analysis for improvement in 6-min walk test with ferric carboxymaltose in patients with heart failure with reduced ejection fraction and iron deficiency. Eur J Heart Fail. 2022; 24: 833– 42. 8Vukadinović D, Abdin A, Anker SD, Rosano GMC, Mahfoud F, Packer M, et al. Side effects and treatment initiation barriers of sodium–glucose cotransporter 2 inhibitors in heart failure: a systematic review and meta-analysis. Eur J Heart Fail. 2022; 24: 1625– 32. 9Butler J, Usman MS, Anstrom KJ, Blaustein RO, Bonaca MP, Ezekowitz JA, et al. Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrum. Eur J Heart Fail. 2022; 24: 2029– 36. 10Rosano GMC, Metra M, Volterrani M. The strategic vision of the 2022–2024 mandate – greater involvement of members, young specialists for an HFA community without borders. Eur J Heart Fail. 2022; 24: 1458– 9. 11Lindberg F, Lund LH, Benson L, Dahlström U, Karlström P, Linde C, et al. Trajectories in New York heart association functional class in heart failure across the ejection fraction spectrum: data from the Swedish heart failure registry. Eur J Heart Fail. 2022; 24: 2093– 104. Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation